Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2025-12-25 @ 10:43 PM
Study NCT ID:
NCT04415567
Status:
COMPLETED
Last Update Posted:
2020-06-04
First Post:
2020-05-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation
Sponsor:
Jinyang Gu
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-22
First Submit QC Date:
None
Study First Post Date:
2020-06-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-01
Last Update Post Date:
2020-06-04
Last Update Post Date Type:
ACTUAL